Esomeprazole and omeprazole may improve the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about greater adverse effects which include drowsiness, although the scientific relevance is minimal in most sufferers – keep track of the client for adverse effects (e.If affected person are not able to resume their standard oral

Esomeprazole and omeprazole could enhance the serum concentrations of benzodiazepines (through CYP2C19 inhibition) resulting in improved adverse effects for example drowsiness, although the medical relevance is reduced for most sufferers – monitor the client for adverse effects (e.If affected individual can't resume their normal oral medication p